Trial ID or NCT#

NCT01046669

Status

RECRUITING

Purpose

To compare the safety and efficacy of the PMX cartridge based on mortality at 28-days in subjects with septic shock who have high levels of endotoxin and are treated with standard medical care plus use of the PMX cartridge, versus subjects who receive standard medical care alone.

Official Title

Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic Shock

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Ronald Pearl
Anesthesiologist
Dr. Richard K. and Erika N. Richards Professor
Glenn M. Chertow
Nephrologist
Professor of Medicine (Nephrology) and, by courtesy, of Health Research and Policy (Epidemiology)
Javier Lorenzo
Anesthesiologist
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

Contact us to find out if this trial is right for you.

CONTACT

Valerie Ojha
498-6210